Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects [Phase 3]
Phase 3 trial assessing the impact of a PCSK9-binding antibody on cognitive health in high cardiovascular risk subjects with dyslipidemia ha…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Effects of Psyllium on Niacin Tolerability [Phase 4]
Phase 4 clinical trial completed to evaluate whether psyllium affects tolerability of niacin in individuals with lipid disorders.
-
CLINICAL_TRIALS withdrawal · 2017-12-02Clinical Trial Update: Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects [Phase 3]
Pfizer has withdrawn the Phase 3 trial evaluating bococizumab for lipid lowering in Asian subjects with primary hyperlipidemia or mixed dysl…
-
FDA approval · 2017-11-21FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's original application for a generic fixed-dose combination of ezetimibe and simvastatin (EZETIMIBE AND SIMVASTATIN). Th…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Is a Smartphone Application Effective as an Oral Medication Adherence Aid [EARLY_Phase 1]
An early-phase 1 trial evaluating a smartphone application to improve oral medication adherence was terminated; the study involved hypertens…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins [Phase 2]
Pfizer completed a Phase 2 multiple-dose study of PF-04950615 (RN316) in patients on maximum statin therapy to evaluate lipid effects, with …
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Effects of Almond Intake on Atherogenic Lipoprotein Particles [NA]
Clinical trial update reports the completion of a study on almond intake and its effects on atherogenic lipoprotein particles in individuals…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Soda and Milk Study [NA]
The Soda and Milk Study, sponsored by UCSF Benioff Children's Hospital Oakland, has completed its clinical trial investigating effects on ob…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706 [Phase 1]
Phase 1 pharmacokinetic study evaluating the potential drug–drug interaction between YHR1705 and YHR1706 has completed; sponsored by Yuhan C…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: A Nutrient Cocktail to Protect Against Physical Inactivity [NA]
A completed clinical trial evaluating a nutrient cocktail intended to protect against metabolic disturbances caused by physical inactivity, …
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins [Phase 2]
Phase 2 multiple-dose study of PF-04950615 (RN316) in patients on high-dose statins has completed, with results posted on 2017-10-11.
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: The Influence of Pilates Exercises Training Volume on Metabolic Outcomes in Dyslipidemic Women. [NA]
A completed clinical trial evaluated how different Pilates training volumes influence metabolic outcomes in dyslipidemic women.
-
FDA approval · 2017-10-02FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Gemfibrozil submitted by Exelan Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2017-09-21Clinical Trial Update: The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C [NA]
A completed trial assessed whether drinking a 3-week soya beverage enriched with plant sterols lowers serum LDL cholesterol in people with d…
-
FDA approval · 2017-09-11FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for fenofibrate from Lupin Pharmaceuticals, Inc., signaling an approved modification to the existing…
-
CLINICAL_TRIALS research · 2017-08-31Clinical Trial Update: Prospective Observational Study of Pravafenix Cap
A prospective observational study update evaluating Pravafenix Cap for the treatment of dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: The Metabolic Effect of Walnuts in Healthy Subjects [NA]
A completed clinical trial from Ludwig-Maximilians-Universität München evaluated the metabolic effects of walnut consumption on lipid metabo…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Nutritional Therapy Improves Dyslipidemia in HIV Infected Teenagers With Antiretroviral Treatment [NA]
A completed clinical trial found that nutritional therapy improves dyslipidemia in HIV-infected teenagers on antiretroviral therapy.
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: Saturated Fatty Acids and HDL Metabolism [NA]
A completed Maastricht University Medical Center study investigates how saturated fatty acids influence HDL metabolism in individuals with d…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Statins at the Primary Care Level [NA]
A clinical trial evaluating the use of statins in primary care for dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia [Phase 4]
A Phase 4 study comparing vardenafil to placebo in men with erectile dysfunction and dyslipidemia has completed. Sponsor: GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events [Phase 3]
A Phase 3 randomized trial of bococizumab in adults with hyperlipidemia or mixed dyslipidemia at risk of cardiovascular events has completed…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events [Phase 3]
Phase 3 randomized trial of bococizumab in people with primary hyperlipidemia or mixed dyslipidemia at risk for cardiovascular events comple…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial [Phase 4]
A randomized, double-blind Phase 4 trial evaluating the effect of a vitamin combination (pyridoxine, folic acid, and cyanocobalamin) on homo…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 [Phase 1]
Phase 1 trial update for CKD-519 in dyslipidemia indicates the study has completed. The snippet does not report results beyond safety/tolera…